rs121434439
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_014236.4(GNPAT):c.632G>A(p.Arg211His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000048 in 1,457,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R211C) has been classified as Pathogenic.
Frequency
Consequence
NM_014236.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPAT | NM_014236.4 | c.632G>A | p.Arg211His | missense_variant | 5/16 | ENST00000366647.9 | NP_055051.1 | |
GNPAT | NM_001316350.2 | c.449G>A | p.Arg150His | missense_variant | 4/15 | NP_001303279.1 | ||
GNPAT | XM_005273313.5 | c.629G>A | p.Arg210His | missense_variant | 5/16 | XP_005273370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPAT | ENST00000366647.9 | c.632G>A | p.Arg211His | missense_variant | 5/16 | 1 | NM_014236.4 | ENSP00000355607 | P1 | |
GNPAT | ENST00000416000.1 | c.602G>A | p.Arg201His | missense_variant | 5/13 | 5 | ENSP00000411640 | |||
GNPAT | ENST00000436239.5 | c.449G>A | p.Arg150His | missense_variant | 4/6 | 3 | ENSP00000402811 | |||
GNPAT | ENST00000644483.1 | c.*318G>A | 3_prime_UTR_variant, NMD_transcript_variant | 6/17 | ENSP00000496537 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251470Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135912
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1457144Hom.: 0 Cov.: 28 AF XY: 0.00000276 AC XY: 2AN XY: 725292
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rhizomelic chondrodysplasia punctata type 2 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 15, 2001 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 08, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GNPAT function (PMID: 11152660). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GNPAT protein function. ClinVar contains an entry for this variant (Variation ID: 6841). This missense change has been observed in individuals with rhizomelic chondrodysplasia punctata type 2 (PMID: 9536089, 11152660). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121434439, gnomAD 0.006%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 211 of the GNPAT protein (p.Arg211His). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at